Background
==========

*Klebsiella pneumoniae* is responsible for a variety of diseases in humans and animals. As a prominent nosocomial pathogen it is mainly responsible for urinary tract, respiratory tract or blood infections \[[@B1]-[@B3]\]. In addition, because of the acquisition of extended-spectrum β-lactamases and carbapenemases, such as the recently described NDM-1 \[[@B4]\], multi, extremely or pan-drug resistant clinical strains are more frequently isolated \[[@B5],[@B6]\]. In addition, *K. pneumoniae* has re-emerged as a cause of community-acquired infections including pneumonia and the characteristic syndrome of pyogenic liver abscess, with possible complications including endophthalmitis or meningitis \[[@B7],[@B8]\]. *K. pneumoniae* is, thus, an important virulent pathogen able to cause serious infections in ambulatory, otherwise healthy hosts and to spread within patients \[[@B5],[@B9]\] that requires a better understanding of the molecular mechanisms underlying the various forms of its pathogenesis.

Major *K. pneumoniae* virulence factors include the capsule, the lipopolysaccharide, iron scavenging systems and adhesins \[[@B3],[@B10]-[@B14]\]. The capsule is one of the most important virulence determinants, protecting against serum bactericidal activity, antimicrobial peptides and phagocytosis \[[@B11],[@B15]-[@B18]\]. At least 77 capsular (K) types can be distinguished, but types K1 and K2 are prominent by their virulence in murine models of infection \[[@B19]-[@B21]\] and by their epidemiological prevalence \[[@B9],[@B18],[@B21],[@B22]\]. However, not all K1/K2-type strains are necessarily virulent, as distinct clonal groups of K1 and K2 differ sharply by their virulence \[[@B23]\]. Reference strain Kp52.145 (derived from B5055, the reference strain of serotype K2) is a highly virulent strain from which important virulence factors, including the large virulence plasmid harboring the regulator of mucoid phenotype (*rmpA*) and the aerobactin cluster, were identified \[[@B10],[@B11],[@B21]\]. Even though a virulence plasmid-cured strain is less virulent than the parental strain, it remained more virulent than other isolates that do not harbor this plasmid \[[@B21]\], showing that factors other than capsule overexpression and aerobactin account for the higher pathogenesis of this strain. Therefore, although known virulence factors are certainly crucial for bacterial survival, protection and interaction with the host, putative new virulence factors that could subvert host cell physiology and response remain yet to be identified.

Comparative genomics of pathogenic and non-pathogenic strains is a powerful approach to identify putative virulence genes. Several draft or complete genomes of clinical isolates of *K. pneumoniae* have been published so far, but only the virulent serotype K1 strain NTUH-K2044 \[[@B24]\] has been described in detail. In order to identify new *K. pneumoniae* K2 virulence factors, we sequenced the genome of the virulent strain Kp52.145, as well as two additional strains of low virulence, SB2390 (serotype K2) and SB3193 (serotype K1). By comparing these three novel genomes to the publicly available genomes of the virulent K1 strain NTUH-K2044 and reference strain MGH 78578, we identified in Kp52.145 putative virulence genes and analyzed their distribution within a diverse collection of *K. pneumoniae* strains. We demonstrate that a gene coding for a phospholipase D family protein (PLD1), located within a type VI secretion system locus, is expressed *in vivo*, is involved in controlling bacterial membrane lipid composition, and is a new virulence factor.

Results and Discussion
======================

Genome assembly and annotation
------------------------------

The genomes of Kp52.145, SB2390 and SB3193 were sequenced by a combination of 454 and Illumina technologies using single and paired-end libraries. Finishing efforts resulted in the complete genome sequence of *K. pneumoniae* Kp52.145 (one chromosome + two plasmids), comprising 5.45 Mbp and 5,314 protein coding genes (Figure [1](#F1){ref-type="fig"}). SB2390 and SB3193 genomes were assembled in 11 and 17 scaffolds, respectively. The GC% of these three genomes ranged from 55.6% to 56.7%. The general features of the *K. pneumoniae* sequenced genomes are summarized in Table [1](#T1){ref-type="table"}.

![***K. pneumoniae*Kp52.145 genome. A)** Chromosome representation: Outermost layers in gray indicate the position of positive and negative strand CDSs. tRNAs are represented in green, while the four virulence-related genomic islands (GI) are in red, the locus coding for anaerobic metabolism in orange, the T6SS gene clusters in blue and capsular synthesis region in yellow. Inner circle represents G + C%. Detail of the T6SS locus III region containing the putative phospholipase (*pld1* gene) (orange) and *sel*1 (pink) genes is shown enlarged. **B)** Plasmids representation: plasmid maintenance genes and IS sequences are shown in blue, proteins with unknown functions in gray, known functions in green, toxin-antitoxin systems in yellow and *rmpA* in red. CDSs, coding sequences.](1741-7007-12-41-1){#F1}

###### 

**General features of the*K. pneumoniae*genomes analyzed**

  **K-type**   **Strain bank ID**    **Scaffolds**   **Size (Mb)**   **% GC**   **Total PCG**   **rRNA operons**   **tRNA genes**   **% coding**   **Plasmids**       **Reference**
  ------------ -------------------- --------------- --------------- ---------- --------------- ------------------ ---------------- -------------- -------------- ------------------------
  K2           3341/Kp52.145               3             5.45          56.4         5,314              8                 85              88             2            This manuscript
  K2           2390                       11             5.62         56.74         5,367              6                 77             86.8            ?            This manuscript
  K1           3193                       16             5.01          55.6         4,793              10                73              92             ?            This manuscript
  K1           NTUH (ST23)                 2             5.24          57.6         4,992              19                76              89             1         Wu *et al*. \[[@B63]\]
  K5           MGH (SB107)                 6             5.31           57          4,776              10                56              85             5              (NC_009648)

The three genomes sequenced in this study are compared to strains NTUH and MGH, previously published. PCG, protein coding genes.

Because Kp52.145 is a highly virulent strain, our analyses were focused on comparing its genome with the genomes of *K. pneumoniae* strains SB2390, SB3193, NTUH-K2044 and MGH78578. According to SEED subsystems annotations \[[@B25]\], about 60% of protein-coding genes for each *K. pneumoniae* genome had predicted functions. More specifically, the largest percentage of annotated genes is involved in the metabolism of carbohydrates (approximately 20%), of amino acids and their derivatives (approximately 10%) and of cofactors, vitamins and prosthetic groups (approximately 8%) \[see Additional file [1](#S1){ref-type="supplementary-material"}\].

Common genome
-------------

To define the common genome of the five strains, we used stringent BlastClust parameters of at least 90% identity and at least 80% coverage. This analysis identified 3,587 coding sequences common to the five genomes. The majority of proteins are involved in metabolic processes, such as energy metabolism and transporters, supporting the general concept that the core genome encompasses essential functions required for survival of the microorganism. The *K. pneumoniae* core genome comprised several sets of genes whose functions are related to bacterial survival in the environment or interaction with its host, and possibly virulence. This was the case, for example, of genes involved in quorum-sensing and biofilm formation, adhesins, and secretion systems, for which examples are detailed below.

Genes encoding for autoinducer-2 and type III fimbria, involved in biofilm formation in *K. pneumoniae*\[[@B26]-[@B28]\], were present in all sequenced strains. In addition, genes coding for synthesis and transport of the poly-β-1,6-N-acetyl-D-glucosamine (PGA) adhesin (KpST66_4915 to KpST66_4918 in Kp52.145 genome) which is required for the structural stability of *Escherichia coli* biofilms \[[@B29]\], and YidE (KpST66_0019), which mediates the hyperadherence phenotype of *E. coli*\[[@B30]\]*,* were also found in the core genome of *K. pneumoniae* strains.

Moreover, the five *K. pneumoniae* genomes contained the genes *bar*A/*uvr*Y (respectively KPST66_0986 and KpST66_3517) and *ycj*X/*ycj*F (KpST66_2441 and KpST66_2442) that may be involved in bacterial fitness and virulence. The two-component system BarA/UvrY (KpST66_3517 and KpST66_0986 in Kp52.145 genome) contributes to biofilm formation in *Salmonella enterica* and is a virulence determinant of urinary tract *E. coli* infections \[[@B31],[@B32]\]. The *E. coli* YcjF protein is expressed in a septicemia murine model of infection in which the *ycj*F mutant is attenuated, thus suggesting its implication in the *in vivo* survival/multiplication of the bacteria \[[@B33]\].

Several putative secretion systems were identified as part of the common genome of the *K. pneumoniae* strains, including one type I secretion system (T1SS) and one type II secretion system (T2SS). T2SS is composed of the pullulanase related genes *pul*A-O that are involved in the pathogenesis of several bacteria \[[@B34],[@B35]\]. *Streptococcus pyogenes* PulA binds to host lung glycogen leading to a strong interaction with alveolar type II cells \[[@B36]\]. Similarly, the alpha-amylase AmyA degrades glycogen into cyclic maltodextrins, which increases the transepithelial translocation of S*treptococcus*\[[@B37]\]. Both *amyA* and *pulA-O* genes are encoded in *K. pneumoniae* genomes, but their functions in this bacterium remain to be characterized. Type VI secretion system (T6SS) putative genes were located in at least three different loci of the *K. pneumoniae* genomes, in accordance with a previous *in-silico* study \[[@B38]\]. T6SS clusters are usually found within pathogenicity islands or on chromosomal regions presenting virulence or host survival biases. Additionally, T6SS has been suggested to assist colonization and infection. Indeed, in a screen that identified *K. pneumoniae* mutants failing to colonize mice \[[@B39]\], two of them were mutants in genes coding for proteins annotated as hypothetical, that have been subsequently re-annotated as T6SS proteins \[[@B38]\]. Type III secretion systems were not found in *Klebsiella*, but type IV secretion systems, possibly corresponding to conjugation apparatus, were present only in some strains (Kp52.145, SB2390 and NTUH-K2044) (Table [2](#T2){ref-type="table"}).

###### 

**Distribution of virulence-related factors among*K. pneumoniae*genomes analyzed**

  **Virulence-factor**    **SB3341**   **SB2390**   **SB3193**   **NTUH**   **MGH**  **Functional role**
  ---------------------- ------------ ------------ ------------ ---------- --------- ----------------------------------------------------------------------------------
  rmpA                        ++           \-           \-          ++        \-     Regulator of capsule expression
  Aerobactin                  \+           \-           \-          \+        \-     Siderophore
  Enterobactin                \+           \+           \+          \+        \+     Siderophore
  Yersiniabactin              \+           \+           \+          \+        \-     Siderophore
  Colibactin                  \+           \-           \-          \-        \-     Genotoxin
  T4SS (virB)                 \+           \+           \-          \+        \-     Conjugative machinery/protein secretion
  T2SS                        \+           \+           \+          \+        \+     Protein secretion
  T6SS                        \+           \+           \+          \+        \+     Protein secretion
  Pld-family                  \+           \-           \-          \-        \-     Lipid metabolism
  Sel1 lipoproteins           \+           \-           \-          \-        \-     Unknown
  cOMP                        \+           \-           \-          \-        \-     Putative cytotoxin
  Igg-like                    \+           \-           \-          \-        \-     Binding to extra cellular matrix compounds
  SEFIR-domain                \+           \-           \-          \-        \-     Potentially hijack IL17R signaling pathways
  Bcl                         \+           \+           \-          \+        \+     Binding to hydrophobic ligands / putative regulation of homeostasis and immunity

Furthermore, the core genome presented a large genomic region located between gly-tRNA and phe-tRNA loci in Kp52.145 genome, containing *frdABCD* genes coding for the fumarate reductase enzymatic complex responsible for fumarate respiration under anaerobic growth of bacteria. This complex is a virulence determinant for *Helicobacter pylori*, *Mycobacterium tuberculosis*, *Actinobacillus pleuropneumoniae* and *S. enterica*, as mutants on these genes are attenuated \[[@B40]-[@B43]\]. The ability to grow anaerobically allows bacterial pathogens to persist in host tissues, including in the lungs. Curiously, this genomic locus encoded in *K. pneumoniae* at least one more protein involved in anaerobic metabolism, the anaerobic C4-dicarboxylate transporter DcuA (KpST66_4904), supporting the idea that this GI provides *K. pneumoniae* advantages to grow under anaerobic conditions, possibly favoring infection. Additional proteins that might be involved in bacterial fitness to environmental stress conditions were encoded in this region. For instance, the putative small multidrug resistance protein SugE (KpST66_4882) has been shown to regulate biofilm formation and capsule expression \[[@B44]\]. A lipocalin-2 bacterial protein Bcl (KpST66_4881) is also encoded in this island of the genome. Eukaryotic lipocalins are small extracellular proteins that bind hydrophobic ligands and fulfill numerous biological functions including regulation of cellular homeostasis and immunity and are regulators of antibacterial defense \[[@B45]\]. Lipocalin2 is for instance a siderophore scavenger for several bacteria, including *K. pneumoniae*\[[@B46]\], as well as a negative regulator of inflammatory response during *Streptococcus pneumoniae* pneumonia \[[@B47]\]. However, the role of bacterial lipocalins is not yet known.

Finally, a phosphatidylserine decarboxylase (KpST66_4873) might be important for the integrity of the bacterial membrane composition, as phospholipid biosynthetic pathways play crucial roles in the virulence of several pathogens \[[@B48],[@B49]\].

Accessory genome
----------------

The accessory genome (genes absent in at least one of the five strains) included a large number of specific coding sequences (CDSs): 743 genes were found only in Kp52.145, 608 in NTUH-K2044, 806 in SB3193, 635 in SB2390 and 488 in MGH78578. About 50% of these genes code for hypothetical proteins or proteins of unknown function. The distribution of the putative virulence-related genes of *K. pneumoniae* among the sequenced strains is summarized in Table [2](#T2){ref-type="table"}. The specific regions or genes of Kp52.145 are detailed below.

Kp52.145 plasmids
-----------------

Strain Kp52.145 possessed two plasmids (Figure [1](#F1){ref-type="fig"}B). The first plasmid of 121 Kb carried the aerobactin cluster and the regulator of mucoid phenotype *rmpA* genes. The presence of this plasmid was previously correlated with the virulence of *K. pneumoniae* K1 and K2 isolates \[[@B21],[@B50]\]. Additionally, a strain cured from this plasmid showed a 6 × 10^4^-fold reduction in virulence, establishing the link between this plasmid and bacterial virulence \[[@B21]\]. In addition to aerobactin and *rmpA*, this plasmid contained genes coding for F-pilin, purine metabolism, insertion sequences and proteins of unknown functions. Kp52.145 also carried a second, previously non-described, plasmid of about 90 Kb. Interestingly, it contained *rmpA2*, a homologue of the regulator of mucoid phenotype *rmpA*, which seems to be involved in capsule expression regulation \[[@B51],[@B52]\]. F-pilin genes, a subtilisin-related serine protease, an AAA + ATPase, the UV protection system UmuD/UmuC and the genes encoding the toxin-antitoxin systems RelE/orf4 and VagD/VagC (Figure [1](#F1){ref-type="fig"}B) were also found on this plasmid. However, the potential role of these genes in virulence remains to be investigated.

Genomic islands identified in the genome of strain Kp52.145
-----------------------------------------------------------

In addition to the capsule synthesis operon and the iron-acquisition systems (yellow and orange boxes in Figure [1](#F1){ref-type="fig"}A, respectively), known to be involved in *K. pneumoniae* virulence, four additional regions of the Kp52.145 genome presented several characteristics of pathogenicity islands (red boxes, Figure [1](#F1){ref-type="fig"}A). These regions are defined by a different GC content in comparison to the average of the genome, represented large chromosomal regions (often \> 30 Kb), were associated with tRNA genes or with the presence of insertion sequences, integrases and transposases, and were present in pathogenic strains while less frequent in less-virulent strains \[[@B53],[@B54]\]. The four GIs present in the Kp52.145 genome were present or partially present in NTUH, but none of them was present in SB2390, SB3193 and MGH 78578, indicating that their occurrence is specific to pathogenic genomes. Figure [2](#F2){ref-type="fig"} shows the four GIs identified, highlighting the putative virulence related genes.

![**Genomic islands (GIs) identified in the genome of Kp52.145.** Positive and negative strand CDSs are represented in gray. Putative virulence related genes are highlighted in different colors. The size of each GI is given in kb. Panel **A**: GI-I, **B**: GI-II, **C**: GI-III and **D**: GI-IV. CDS, coding sequences.](1741-7007-12-41-2){#F2}

Genomic island 1 (GI-1): ICE-Kp1-like region
--------------------------------------------

The largest GI found in the Kp52.145 genome comprised 133,679 bp, presented a GC content of 52%, was inserted in an asn-tRNA locus and encoded 92 CDSs (Figure [2](#F2){ref-type="fig"}A). Most of the protein-coding genes found in this region were described as part of the IceKpI GI of NTUH-K2044 \[[@B55],[@B56]\], although several differences were found. Kp52.145 GI-I begins at asn tRNA locus followed by several uncharacterized proteins and insertion sequence elements. GI-I coded for the synthesis of two polyketide/nonribosomal peptides (yersiniabactin and colibactin) and for the conjugative transfer machinery (T4SS) that allows horizontal transfer of the island \[[@B56]\]. In contrast to the previous description of IceKpI \[[@B56]\], the Kp52.145_GI-I carried colibactin and did not contain the region coding for *vagC-vagD*, *iroN-iroB-iroC-iroD* and *rmpA* genes which are carried only by the 121 kB plasmid in Kp52.145.

Genomic island 2 (GI-II)
------------------------

We describe here a novel GI (GI-II). It is a 29,829 bp island, with a GC content of 49% and coding for 28 CDSs which is inserted in a leu-tRNA locus (Figure [2](#F2){ref-type="fig"}B). Potential pathogenesis-related genes coded for a putative cytotoxic outer membrane protein (cOMP, KpST66_4736) and a polyamine ABC transport system (KpST66_4729 to KpST66_4732). cOMP closest known homologue (34% identity) was a *Plesiomonas shigelloides* predominant virulence factor proposed to trigger cell death in host cells following infection \[[@B57]\]. Polyamine biosynthesis and transport mechanisms were intricately linked to fitness, survival, biofilm formation and pathogenesis, for instance in *S. pneumoniae* and *Yersinia pestis*\[[@B58],[@B59]\]. Additionally, this GI encoded a 4-phytase gene (KpST66_4736), *ugpQ3* (KpST66_4728) and *xylA*, *xynT*, *xynB*, *xylR* (KpST66_4724 to KpST66_4727) that are involved in xylose metabolism.

Genomic island 3 (GI-III)
-------------------------

The third GI is characterized by a 49,657 bp region presenting a G + C content of 51% and contained 66 CDSs, most of them coding for phage structural proteins (Figure [2](#F2){ref-type="fig"}C). This GI included genes coding for proteins with homologues that were shown to play a role in bacterial adhesion and immune system escape \[[@B60]-[@B62]\]. These proteins encoded for an immunoglobulin domain-containing protein (KpST66_1506), a peptidase S24-like protein (KpST66_1511), two HNH family endonucleases (KpST66_1468 and 1486) and an exonuclease (locus 1464).

Genomic island 4 (GI-IV)
------------------------

The forth island (GI-IV) was mainly comprised of phage-related genes. Among the 42 CDSs encoded within this genomic region, one gene coded for a SEFIR-domain containing protein (KpST66_1945; Figure [2](#F2){ref-type="fig"}D). A SEFIR domain is usually found in IL17 receptors and SEF proteins, acting in eukaryotes signaling pathways. Very little is known about prokaryotic SEFIR-containing proteins. Structural analyses suggested that these bacterial SEFIR domains share structural and electrostatic similarity with their mammalian homologues and, thereby, could potentially subvert host immunity by hijacking the IL17R signaling pathways \[[@B63]\]. Notably, local production of IL-17 is a significant factor in effective host defense against Gram-negative bacteria, including *K. pneumoniae*\[[@B64]\]. Therefore, further studies are required to elucidate whether KpST66_1945 is implicated in *K. pneumoniae* pathogenesis.

Distribution of GIs among *K. pneumoniae* strains
-------------------------------------------------

To investigate the distribution of the described GIs in *K. pneumoniae*, the presence of the putative virulence-related genes was searched using BlastN in 171 genomes, including 119 publicly available and 52 unpublished genomes (Bialek-Davenet, Brisse *et al*., unpublished work) representing 47 different sequence types (STs). Whereas the SEFIR-domain containing protein gene of GI-IV was only found in two (1.2%) isolates of sequence type ST15, the three other GIs described herein were more distributed among *K. pneumoniae* isolates (Table [3](#T3){ref-type="table"}). GI-II genes were present in a total of 11 (6.4%) isolates, most of which belonged to ST375, ST65 and ST25, which were associated with severe infections caused by isolates of capsular serotype K2 \[[@B9],[@B65]\]. The genes of GI-II were always found in synteny. GI-III genes were observed in only seven (4.1%) isolates dispersed in several unrelated STs. The distribution of the ICE*Kp*I element (similar to GI-I) has been previously analyzed \[[@B55]\].

###### 

**Prevalence of the genomic islands among*K. pneumoniae*isolates**

  **Genomic island**   **Virulence-related features**    **Prevalence (%)**   **Remarkable STs**
  -------------------- -------------------------------- -------------------- --------------------
  GI-I                 Colibaction                             3.5^a^                 \-
  Yersiniabactin                                                             
  GI-II                cOMP                                     5.8               3775,65,25
  4-phytase                                                                  
  GI-III               Igg-like                                 8.1               Dispersed
  Exonuclease          57.6                                    375,65        
  GI-IV                Sefir-domain                             1.7                   \-
  T6SS insertion       PLD1                                     7.0                 380,35
                       Sel 1                                    7.0                 380,35

^a^according to ref. \[[@B55]\]. Prevalence of virulence-related features encoded in GI-II, GI-III, GI-IV and T6SS insertion was based on \>90% identity and \>50% coverage in the length of the genes, using a database of 171 *Klebsiella* genomes representative of 47 different STs. STs, sequence types.

T6SS locus III insertion
------------------------

Recently, three different T6SS loci were defined in *K. pneumoniae*\[[@B38]\]. Within these loci, three putative valine-glycine repeat (Vgr) proteins and two hemolysin-coregulated proteins (Hcp) were described as potential effector proteins, through their sequence similarities to *Vibriocholerae* and *Pseudomonasaeruginosa* effector proteins \[[@B65]-[@B68]\]. Accordingly, the Kp52.145 genome also presented three conserved T6SS loci syntenic to those previously described. The first two loci were identical in composition and orientation to the previously described ones. The third one, locus III, had conservation of adjacency limited to the *imcF/impG/impH* and *impJ/ompA/vgrG* gene clusters, as a region with nine genes was inserted between these two clusters. This insertion encoded for one hypothetical protein, five putative Sel-1 repeat containing lipoproteins and three putative phospholipase D family proteins (Figure [1](#F1){ref-type="fig"}A). Flanking sequences suggesting how this region was inserted were not found.

Sel1 lipoproteins are poorly characterized and there was no evidence for their function in *K. pneumoniae*, but they are essential in *Legionellapneumophila* for invasion of host cells where they influence vacuolar trafficking of bacteria \[[@B69]\]. The three open reading frames encoding putative phospholipase D proteins in strain Kp52.145 encoded one full length protein (KpST66_3368, 623 aminoacids), one C-terminal region (KpST66_3371, 187 aa) and one N-terminal region (KpST66_3372, 317 aa). Phospholipase D family proteins have been described as important for host cell invasion, bacterial dissemination and disease progression \[[@B70]-[@B73]\]. The bacterial phospholipase D family comprises at least four classes of proteins with distinct functions: true phospholipase D, cardiolipin synthase, phosphatidylserine synthase and endonuclease \[[@B74]\]. Full length *K. pneumoniae* PLD1 and its closest homologs all presented the conserved motif HXK(X)~4~D and a serine or threonine approximately eight residues after asparagine (Figure [3](#F3){ref-type="fig"}), but no other conserved domain was described in each family, thus making it difficult to infer protein function only by sequence analysis.

![**Sequence alignment of Kp52.145 (Kp) PLD1 and its closest related sequences: putative phospholipase D family protein from*Pseudomonas syringae*(PS) and cardiolipin synthases from*P. putida (PP)*,*Staphylococcus aureus (SA), Bacilus subtilis (BS)*and*E. coli (EC)*.** The rectangles indicate the phospholipase D active site regions and the asterisk points to the corresponding transposon insertion site in *pld1* mutant strain.](1741-7007-12-41-3){#F3}

In order to obtain evidence that the product of these three genes coding either for full length or partial PLD-family proteins are important for bacterial survival *in vivo*, we checked by RT-PCR for their mRNA expression. We observed that these genes are expressed both in bacteria grown for four hours in Trypto Casein Soy broth (GTCS) medium, as well as in the lungs of mice infected for 24 hours (data not shown). These results prompted us to further check for a putative involvement of the full length PLD gene, called *pld1*, on *K. pneumoniae* virulence.

Involvement of the phospholipase D family protein gene *pld1* in KP 52.145 virulence
------------------------------------------------------------------------------------

As PLD-family proteins have been shown to be involved in virulence \[[@B75]-[@B77]\], we decided to characterize the role of the full length PLD1 protein. We first tested a *pld* mutant strain in a *K. pneumoniae* murine model. Mice were infected intranasally with 10^8^ of either the wild-type bacteria, a *pld1* mutant, or the mutant strain complemented with a plasmid expressing the putative PLD1 protein (pPLD), and their survival was monitored for seven days. Interestingly, the mutant strain appeared avirulent in a mouse model of acute pneumonia while mice infected with the wild-type and the complemented strain succumbed in less than one week (Figure [4](#F4){ref-type="fig"}). However, the wild-type, the mutant and the complemented mutant strains grew equally well in Luria-Bertani broth (LB) broth (data not shown). These results indicated that the *pld1* mutant was strongly attenuated *in vivo*, thus showing an important role for PLD1 in virulence.

![**PLD1 involvement in*K. pneumoniae*virulence.** Mice survival after infection with *K. pneumoniae* Kp52.145 wild-type, *pld1* mutant and complemented strains. Data are representative of seven mice per group from two independent experiments. Standard deviation is shown. PLD, phospholipase D.](1741-7007-12-41-4){#F4}

To analyze the frequency and clonal distribution of the *pld1* gene in *K. pneumoniae*, the 171 genomes were analyzed using BlastN. We observed that besides ST66, represented by strain Kp52.145, *pld1* was present in 10 strains (6.4%) belonging to ST380, ST679, ST67 (*K. pneumoniae subsp. rhinoscleromatis*) and ST35, but in none of the other isolates. It is interesting to note that ST380 was associated with severe *K. pneumoniae* infections \[[@B9],[@B65]\] and that *K. pneumoniae subsp. rhinoscleromatis* is the only *Klebsiella* strain to be able to survive intracellularly in macrophages \[[@B78]\].

Functional characterization of PLD1
-----------------------------------

In order to demonstrate the phospholipase activity of PLD1 and characterize its involvement in lipid metabolism, the lipid composition of wild-type and mutant strains was analyzed by thin-layer chromatography (TLC). A remarkable lipid spot was absent from the *pld1* mutant in comparison with the complemented strain, suggesting that the putative PLD1 is involved in lipid metabolism \[see Additional file [1](#S1){ref-type="supplementary-material"}\]. To reinforce this result, a plasmid carrying the *pld1* gene was inserted into *E. coli* strain SD9 \[[@B79]\]. This strain is deficient in phosphatidylserine and cardiolipin, thus presenting a simpler lipid composition than its parental strain and Kp52.145. Lipid profiles of SD9 and complemented strains had a different lipid composition. Notably, the PLD1-expressing strain contained an additional lipid spot in comparison to the SD9 strain, suggesting that PLD1 is responsible for this difference (Figure [5](#F5){ref-type="fig"}A). SD9 wild-type strain also presented an extra lipid spot in comparison to the PLD1*-*expressing strain, possibly representing the PLD1 substrate (Figure [5](#F5){ref-type="fig"}A). Densitometric analysis of iodine-stained lipids on TLC plates revealed that this lipid spot corresponded to 21% of the total amount of lipids in SD9 strain, but only 6% of SD9 complemented with a plasmid expressing *pld1*. Mass spectrometry (MS) analysis of total lipid extract was carried out to identify such lipid. Comparing lipid profiles by MS, we found a lipid of mass 788.4 present only in the PLD1*-*deficient strain (Figure [5](#F5){ref-type="fig"}B) and identified it as phosphatidyl glycerol (PG) using the LipidMaps database.

![**PLD1 involvement in lipids metabolism. A)** TLC lipid profiles of *E. coli* strain SD9 and SD9 + pPLD. Red circle indicates phosphatidyl glycerol. Blue circle represents the lipid present specifically upon *pld1* expression. **B)** Mass spectrometry profiles of *E. coli* strain SD9 and SD9 + pPLD lipids. The red arrow points to m/z 789.4 exclusively found in wild-type strain. TLC, thin-layer chromatography.](1741-7007-12-41-5){#F5}

As mentioned above, the bacterial PLD-family proteins can be classified in four subfamilies. One of them, the cardiolipin synthase is able to convert two PG molecules into glycerol and cardiolipin, or to catalyze the opposite reaction, leading to PG formation \[[@B80]\]. Our results suggest that PLD1 belongs to the cardiolipin synthase subfamily and that it plays a role in balancing the PG and cardiolipin content.

It has been shown that humans and mice with bacterial pneumonia have markedly elevated amounts of cardiolipin in lung fluid and that it impairs surfactant function, lung mechanics, modulation of cell survival and cytokine networks and lung consolidation \[[@B81]\].

There is evidence that bacteria are able to adjust their relative concentrations of phosphatidylethanolamine and PGs when subjected to environmental stresses. Such an alteration in headgroup composition seems to be a means for changing membrane permeability and, hence, preserving stability \[[@B82]\]. Therefore, we hypothesize that PLD1 alters the membrane composition and charge, affecting bacterial interaction with the host environment.

Recently, Russel *el. al*. demonstrated that diverse phospholipase proteins encoded within the T6SS loci of several prokaryotic genomes are antibacterial effectors, conferring competitive advantages on the donor strain during interbacterial interactions \[[@B83]\]. These proteins are generally designated as 'T6SS Lipase Effectors' (Tle) and classified in five sub-families, according to the sequence conservation and number of catalytic motifs present. Kp52.145 PLD-family protein could be considered a Tle5 member, as it presents two conserved HxKxxxxD motifs. However, in the Kp52.145 genome we did not identify any gene similar to the cognate immunity genes - a hallmark of the genomic islands described by Russel *et al*. Moreover, we did not observe such an antibacterial effect of Kp52.145 or its PLD1 mutant strain upon competition with *E. coli* \[see Additional file [1](#S1){ref-type="supplementary-material"}\]. These results showed that *pld1* is implicated in virulence without being an anti-bacterial factor and is, so far, unique.

Conclusions
===========

This study presents a comparative analysis of the complete genome sequence of the high virulence reference strain Kp52.145, a derivative of the K2 reference strain B5055. It revealed five genomic regions possibly involved in bacterial virulence. One gene, *pld1*, was shown to be involved in virulence in a mouse model of pneumonia and revealed a novel implication of lipid metabolism in *K. pneumoniae* pathogenesis. Future analysis of additional putative virulence factors such as Sel1 lipoproteins, VgrG, Hcp, Bcl, cOMP and Sefir-domain containing protein are required for a comprehensive understanding of *K. pneumoniae* core virulence genes.

Methods
=======

Selection of isolates for genome sequencing/bacterial strains
-------------------------------------------------------------

Strain Kp25.145 (a derivative of B5055, the reference strain of serotype K2) is a laboratory strain used to study *K. pneumoniae* pathogenesis \[[@B11],[@B21]\] and was chosen as the focus of this work. SB2390 (cur15505, isolated in Curaçao, 2002, urinary tract infection; belongs to ST14) and SB3193 (IPEUC-744, isolated from a metritis case in a mare, 1981 in France; belonging to ST82) \[[@B23]\] are non-virulent strains that were sequenced to allow the comparison between virulent and non-virulent strains.

The *pld1* transposon mutant was isolated by Anna Tomas and Jose Bengoecheoa during a screen of a *K. pneumoniae* mutant library made by Tn5 transposon insertion (manuscript in preparation). In this mutant, the transposon was inserted at position 1,625 of *pld1* gene.

The complementation of the mutant strain was achieved through bacterial transformation using electrocompetent cells and a plasmid carrying *pld1* gene. *pld1* gene was amplified by PCR and cloned at the multiple cloning site of puc18 plasmid. Cloning was confirmed by DNA sequencing.

Genome sequencing and assembly
------------------------------

*K. pneumoniae* strains were sequenced using a combination of 454 and Illumina reads. Single and paired-end 454 reads with an average of 400 nucleotides were assembled into contigs and scaffolds by Newbler. Illumina reads of about 76 or 36 nucleotides were aligned to scaffolds in order to confirm and correct possible homopolymer errors in the 454 reads. Coverage was as follows: Kp52.145 genome: 170 X using GAIIX (76 nt) + 13.8 X using MP titanium + 18 X using SR titanium; SB2390 genome: 81 X using GAIIX (36 nt) + 6.4 X using MP titanium + 22 X using SR titanium; SB3193 genome: 209 X using GAIIX (76 nt) + 5.4 X using MP titanium + 20 X using SR titanium.

Following the primary assembly of the genomes, an *in silico* finishing approach, based on the methods described by Pop *et al*. \[[@B84]\], was performed in order to identify small and identical repeats on the genomes. In such cases and without high quality bases discrepancies, the contigs containing the small repeats were manually duplicated and added to the assembly.

Scaffolds were aligned to experimentally determined *Bgl*II optical maps generated by OpGen company from purified chromosomal DNA, using MapSolver version 3.1 software. Such alignments were used to check for the quality of the assemblies. Additionally, specific pairs of primers were designed in order to close all remaining gaps. PCR products were purified in NucleoFast 96 plates (Macherey Nagel, Düren, Germany) and aliquots were used for sequencing reactions with the BigDye Terminator Cycle Sequencing Ready reaction Kit (Applied Biosystems, Foster City, CA, USA) on a ABI Prism 3730XL DNA Analyzer (Applied Biosystems). The resulting sequences were added to the previous assembly using Phred/Phrap/Consed.

The sequences of *K. pneumoniae* genomes have been deposited to the European Nucleotide Archive and are accessible under the accession numbers: FO834904, FO834905 and FO834906 (strain Kp52.145), CCBO00000000 (strain SB2390) and CCCQ000000000 (strain SB3193).

Functional annotation of genomes
--------------------------------

In order to gain functional insights about the genome sequences, protein-coding genes were predicted and annotated using the CAAT-box genome browser \[[@B85]\], using a combination of GeneMark predictions and Blastx results against the Uniprot database. All the putative open reading frames (ORF) longer than 120 nucleotides presenting similarity to sequences of the Uniprot database or positive GeneMark result were considered for further analysis. The final set of CDSs underwent a manual annotation process based on description of similarity. Pfam and COG database searches, as well as SignalP, TMHMM and PredTMBB predictions were performed to improve the degree of annotation confidence, if necessary. CDSs were described as 'highly similar to' , 'similar to' or 'weakly similar to' if they presented more than 70%, between 50% and 69% or less than 50% similarity to the protein hit sequence. Additionally, information on partial homology was included. The start codon for each CDS was automatically chosen and manually validated, based on a combination of GeneMark results and Blast alignments. RAST was used to classify proteins in functional categories. Structural RNAs were searched using tRNAscan.

The common genome of the five strains was determined using the BlastClust algorithm \[[@B86]\] using minimum parameters of 90% identity and 80% length coverage for proteins to be included in the same cluster.

RT-PCR
------

Lungs of control or Kp52.145-infected mice were homogenized in cold TRI reagent (Sigma, Gillingham, Dorset, UK) using a Precellys lysing kit (Precellys, Saint Quentin en Yvelines, France). Total lung and bacterial mRNAs were extracted according to the manufacturer's instructions. RNA (2 μg) was reversed transcribed in cDNA using Superscript II enzyme (Invitrogen, Foster City, CA, USA). Aliquots were used in PCR reactions using specific primers \[see Additional file [1](#S1){ref-type="supplementary-material"}\].

Animal experiments
------------------

BALB/cJ mice were purchased from Janvier (Le Genest St. Isle, France). Mice were housed under standard conditions of feeding, light and temperature with access to food and water *ad libidium*. Experiments were performed according to the national and Institut Pasteur guidelines for laboratory animal experiments. Protocols were approved by the Institut Pasteur animal care and use committee (protocol 05--59) and the Direction des Services Vétérinaire de Paris (permit 75--713 to RT). Six- to eight-week-old mice were anesthetized with acepromazine (Calmivet, 1.5 mg/kg, Vetoquinol, Lure, France). and ketamine (Imalgene, 31.25 mg/kg, Merial, Lyon, France). and then infected intranasally with 20 μl bacterial suspension. The virulence of *K. pneumoniae* strains was tested on six-week-old BALB/c mice, as previously described \[[@B23]\]. Seven mice per test condition were infected with 10^8^ bacteria. Mice were followed every day for one week. Experiments were performed at least twice.

Thin-layer chromatography and mass spectrometry of lipids
---------------------------------------------------------

Bacterial lipids were extracted by the method of Bligh and Dyer \[[@B87]\]. Briefly, bacterial stationary-phase cultures were concentrated 10 times and mixed with chloroform:methanol. After centrifugation at 1,000 rpm for five minutes, the organic phase was recovered. Lipid profiles were analyzed by two-dimensional TLC using TLC Silica gel 60 F~254~ plates (Merck, Whitehouse Station, NJ, USA). as the stationary phase and a chloroform 9:1 methanol mixture as the mobile phase in both dimensions. Staining was performed by iodine vapor. TLC calibrated images were aquired in ImageScanner using LabScan v5.0 software. The relative intensity of each spot was calculated in ImageMaster two-dimensional Platinum v7.0 software. Alternatively, lipid extracts were analyzed by MS and MS/MS in an ESI-Q-Tof Micro (Waters), in positive ion mode. Resolution was typically lower than 10 ppm.

Anti-bacterial competition assays
---------------------------------

Competition assays were performed as previously described \[[@B88]\]. Briefly, *K. pneumoniae* Kp52.145 or its *pld1* mutant cells grown overnight on an agar plate were resuspended in LB, normalized to OD~600~ of 0.5 and mixed at a ratio of 5:1 with a spontaneous nalidixic acid (nal) resistant mutant strain of *E. coli* MG1655. The mixture was incubated for four hours on a prewarmed agar plate. Recovered cells were plated out on antibiotic selective media and viable cells were reported as the total number recovered per co-culture spot. *Serratia marcescens* DB10 was used as a positive control.
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**1) Distribution of*K. pneumoniae*Kp52.145 genes, according to RAST categories.** Each functional category is represented in a different color. The total number of genes per category is shown. 2) pld PCR assay. A collection of 42 virulent and non virulent clones was screened by PCR for *pld* gene. Strains containing *pld* gene are indicated by (+) and the absence of *pld* gene is (-). 3) TLC lipid profiles of *K. pneumoniae* Kp52.145 wild-type (left panel) and *pld* mutant strains (right panel). Black circles indicate differentially expressed lipids. 4) Bacterial competition assay. Anti-bacterial activity was measured as the number of *E. coli* cells recovered after the co-culture with *K. pneumoniae* Kp52.145 wild-type and *pld* mutant strains. *S. marcesens* was used as a positive control strain. 5) List of primers used for RT-PCR analysis.
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